Vaccination in oncology practice and predictors

Alkan, Ali; Karcı, Ebru; Yaşar, Arzu; Tuncay, Gülseren; Köksoy, Elif Berna; ÜRÜN, Muslih; Şenler, Filiz Çay; Demirkazık, Ahmet; Utkan, Güngör; Akbulut, Hakan; Ürün, Yüksel

doi:10.1007/s00520-017-3675-y

Cited by 13 publications

(11 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, this difference cannot be explained by age because in the other studies, half of the participants were also over 65 years old and, therefore, had another indication for receiving in uenza vaccinations. In a study by Alkan et al, factors associated with a low VC against in uenza were age below 65 years, insu ciently informed oncologist, and doubts about the effectiveness of the vaccine among medical staff [19]. However, in a study conducted by Toleman et al on cancer patients in the UK, in uenza VC was 68.1% [20].…”

Section: Discussionmentioning

confidence: 99%

Vaccination coverage in cancer outpatients: An interventional multicenter before/after study.

Rivière

Penel

Faure

et al. 2021

JCO

View full text Add to dashboard Cite

e24026 Background: Despite largely diffused guidelines, Pneumococcal and Influenza vaccination coverage (VC) remains insufficient in cancer patients receiving chemotherapy. We evaluated VC and carried out an interventional study to improve VC in cancer patients treated in 3 medical oncology departments in 3 hospitals of North-of-France. Methods: Using a standardized questionnaire, we assessed the VC in adult cancer patients receiving anticancer treatment in day hospital between 02 and 07 Dec. 2019. Then, in each hospital, we organized trainings with physicians to discuss the current vaccination guidelines (January 2020). Finally, to assess the impact of this intervention on Pneumococcal and Influenza VC, we have conducted a similar survey using the same questionnaire in March 2020. Since there were no specific guidelines on Diphtheria-Tetanus-Pertussis (DTP) VC and we did not expect an improvement, we have monitored DTP VC as internal control. Results: 272 patients have been enrolled in the “before study” in the 3 hospitals, whereas 156 patients have been enrolled in the “after study” in only 2 hospitals (the after-study was not feasible in 3rd hospital because of COVID-19 pandemic national containment). Predictors associated with DTP VC was age, with Pneumococcal VC was center and with Influenza VC were age, gender and tumor histology (adenocarcinoma vs others). Influenza VC was significantly improved after intervention (42.6 vs 55.1% with p = 0.016) especially in fragile patients, but Pneumococcal VC was not (11.8 vs 15.4% with p = 0.357). Conclusions: As expected, VC was very low in cancer patients, our figures are consistent with literature data. The impact of intervention (training of physicians) is limited without improvement of Pneumococcal VC. We presume that this increase in Influenza VC mainly reflects the overall result of national Influenza vaccination campaign.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccination coverage in cancer outpatients: An interventional multicenter before/after study.

Rivière

Penel

Faure

et al. 2021

JCO

View full text Add to dashboard Cite

show abstract

“…In addition, we think that the more active study of the vaccination unit and the higher inclusion of this issue in the education curriculum of the healthcare providers are effective in increasing the influenza vaccination rates at our hospital. Also, concerning this increase, we think that the priority given to this issue in the institutions and organizations that make health-related decisions in our country has also played a key role (10,11,(21)(22)(23)(24)(25).…”

Section: Discussionmentioning

confidence: 99%

“…Lack of time and lack of knowledge or experience about vaccination were the most common limitations. Experience with autologous or allogeneic bone marrow transplant patients was related with more tendency to evaluate patients for vaccination (23).…”

Section: Discussionmentioning

confidence: 99%

Seasonal influenza vaccination in chronically ill children : the experience of a tertiary healthcare center

Uzun¹

2020

Turkish Journal of Pediatric Disease

View full text Add to dashboard Cite

Objective: Seasonal influenza vaccination is place an important role in the prevention of children with chronic disease. However, the vaccination rate in this group is sub-optimal and far from the public health goal. The aim of this study is to contribute to research addressing the need for a higher rate of seasonal influenza vaccination of chronically ill children at our center. Material and Methods: This study was conducted in Ankara Child Health and Diseases, Hematology Oncology Training and Research Hospital and is a single-center retrospective study. The study covers 3 consecutive flu seasons between October 2015 and May 2018. Results: Seasonal influenza vaccine was administered to 315 chronically ill children in 3 consecutive flu seasons. During three seasons between October 1, 2015 and May 31, 2018, 12,690 chronically ill children were admitted to our center in the same diagnoses as children who were vaccinated. Of these 315 children, 87.0% had asthma, 4.4% had selective deficiency of immunoglobulin A, 2.2% had nephrotic syndrome, 1.6% had diabetes mellitus, 1.3% had cystic fibrosis, 1.3% were hematopoietic stem cell transplantation patients, 0.96% had cerebral palsy, 0.64% had Duchenne muscular dystrophy, and 0.6% had acute lymphoblastic leukemia. Conclusion: In this study, seasonal influenza vaccination rates of chronically ill children increased gradually in these 3 influenza seasons. However, the number is still low. It is clear that we need a plan to increase the vaccination rates of this patient group at our center.

show abstract

“…People who have verified hematological or solid malignant tumors and receive chemotherapy are at high risk of influenza-related complications. Systematic immunization could prevent further health decline and poor outcomes in these patients (44). Although it seems that children who have solid tumors have a more favourable immunity compared to children with haematological malignancies, vaccination recommendations for this population group correspond to those for adult patients (45,46).…”

Section: Seasonal Influenza Immunization and People With Malignant Tumorsmentioning

confidence: 99%

Factors associated with seasonal influenza immunization in people with chronic diseases

Arsenović¹,

Gazibara²

2021

Medicinski podmladak

View full text Add to dashboard Cite

Annually, at a global level, 3 to 5 million people present severe clinical forms of seasonal influenza and up to 650 000 people die of influenza-related complications. People with chronic diseases, such as cardiovascular, pulmonary, renal, hepatic, neurologic, hematologic and metabolic diseases or those reciveing immunosuppressive therapy, constitute a high-risk population group for the development of influenza-related complications, more severe clinical course and poorer health-related outcomes. Due to all of the above, people with chronic diseases are of high priority to receive the influenza vaccine. Immunization represents the key strategy to prevent influenza both in terms of effectiveness and health care costs. Based on the World Health Organization (WHO) recommendations, adequate seasonal influenza immunization coverage among people with chronic diseases is set at 75%. However, few countries achieve this threshold. Understanding predictive factors of vaccination, at different levels of health care delivery (such as individuals, service providers, health policy), is essential to secure acceptance of influenza immunization and achieve the recommended level of vaccination coverage. In this mini review, all the available evidence regarding seasonal influenza vaccination coverage is summarized, alongside factors associated with vaccine uptake in people with chronic diseases as a whole, as well as according to specific diseases such as: cardiovascular and pulmonary disorders, diabetes and cancer. Based on the reviewed empirical evidence, a wide spectrum of factors associated with immunization against influneza was found in people who have chronic diseases. Although diverse, these factors can be systematized into 4 distinctive groups: socio-demographic characteristics, individual attitudes and beliefs, health promoting behaviors and factors related to the health care system. Further efforts are needed to improve the seasonal influenza vaccination coverage. The immunization strategy needs to include the health care system and the community to support people with chronic diseases to continously accept the influenza vaccine.

show abstract

Vaccination in oncology practice and predictors

Abstract: Degree of experience in oncology especially in bone marrow transplant units and total number of patients seen per day are important predictors of vaccination practice in oncology. The frequency of recommendation increases with degree of experience, knowledge, and visit time per patient.

Cited by 13 publications

References 19 publications

Vaccination coverage in cancer outpatients: An interventional multicenter before/after study.

Vaccination coverage in cancer outpatients: An interventional multicenter before/after study.

Seasonal influenza vaccination in chronically ill children : the experience of a tertiary healthcare center

Factors associated with seasonal influenza immunization in people with chronic diseases

Contact Info

Product

Resources

About